These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 22202584

  • 1. Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies.
    Kusamura S, Baratti D, Deraco M.
    Ann Surg; 2012 Feb; 255(2):348-56. PubMed ID: 22202584
    [Abstract] [Full Text] [Related]

  • 2. Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres.
    Kusamura S, Baratti D, Virzì S, Bonomi S, Iusco DR, Grassi A, Hutanu I, Deraco M.
    J Surg Oncol; 2013 Mar; 107(4):312-9. PubMed ID: 22926536
    [Abstract] [Full Text] [Related]

  • 3. Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity.
    Kusamura S, Baratti D, Younan R, Laterza B, Oliva GD, Costanzo P, Favaro M, Gavazzi C, Grosso F, Deraco M.
    Ann Surg Oncol; 2007 Sep; 14(9):2550-8. PubMed ID: 17558537
    [Abstract] [Full Text] [Related]

  • 4. Incidence of postoperative pancreatic fistula and hyperamylasemia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Kusamura S, Baratti D, Antonucci A, Younan R, Laterza B, Oliva GD, Gavazzi C, Deraco M.
    Ann Surg Oncol; 2007 Dec; 14(12):3443-52. PubMed ID: 17909918
    [Abstract] [Full Text] [Related]

  • 5. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.
    Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, Deraco M.
    Cancer; 2006 Mar 01; 106(5):1144-53. PubMed ID: 16456817
    [Abstract] [Full Text] [Related]

  • 6. Feasibility of delayed hyperthermic intraperitoneal chemotherapy in case of unforeseen complications.
    Mohr Z, Hirche C, Liebeskind U, Rau B, Hünerbein M.
    Eur Surg Res; 2011 Mar 01; 47(1):19-25. PubMed ID: 21540615
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.
    Chua TC, Quinn LE, Zhao J, Morris DL.
    J Surg Oncol; 2013 Aug 01; 108(2):81-8. PubMed ID: 23737041
    [Abstract] [Full Text] [Related]

  • 11. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M, Cioppa T, DE Marco G, Bing C, D'Amico S, D'Alessandro M, Fiorentini G, DE Simone M.
    In Vivo; 2009 Aug 01; 23(4):639-44. PubMed ID: 19567401
    [Abstract] [Full Text] [Related]

  • 12. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
    Sardi A, Jimenez WA, Nieroda C, Sittig M, Macdonald R, Gushchin V.
    Eur J Surg Oncol; 2013 Nov 01; 39(11):1207-13. PubMed ID: 24007834
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique.
    Kusamura S, Deraco M, Baratti D, Inglese MG, Costanzo P, Favaro M, Manzi R, Gavazzi C.
    J Exp Clin Cancer Res; 2003 Dec 01; 22(4 Suppl):207-12. PubMed ID: 16767933
    [Abstract] [Full Text] [Related]

  • 17. Hepatobiliary procedures in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Glockzin G, Renner P, Popp FC, Dahlke MH, von Breitenbuch P, Schlitt HJ, Piso P.
    Ann Surg Oncol; 2011 Apr 01; 18(4):1052-9. PubMed ID: 21046262
    [Abstract] [Full Text] [Related]

  • 18. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M.
    Ann Surg Oncol; 2008 Feb 01; 15(2):526-34. PubMed ID: 18043976
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.